Ingrid Pabinger-Fasching

1.0k total citations
46 papers, 757 citations indexed

About

Ingrid Pabinger-Fasching is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Ingrid Pabinger-Fasching has authored 46 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Genetics. Recurrent topics in Ingrid Pabinger-Fasching's work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Hemophilia Treatment and Research (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Ingrid Pabinger-Fasching is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (14 papers), Hemophilia Treatment and Research (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Ingrid Pabinger-Fasching collaborates with scholars based in Austria, Germany and United States. Ingrid Pabinger-Fasching's co-authors include Klaus Lechner, Christine Mannhalter, Claude Négrier, Massimo Morfini, Iris Jacobs, Andreas Tiede, Elena Santagostino, C. Voigt, Robert Klamroth and H. Niessner and has published in prestigious journals such as Blood, Annals of Oncology and American Journal of Kidney Diseases.

In The Last Decade

Ingrid Pabinger-Fasching

45 papers receiving 708 citations

Peers

Ingrid Pabinger-Fasching
S.J. Machin United Kingdom
Jeffrey S. Dlott United States
J Fehr Switzerland
Soma Mohammed Australia
T. McNally United Kingdom
S.J. Machin United Kingdom
Ingrid Pabinger-Fasching
Citations per year, relative to Ingrid Pabinger-Fasching Ingrid Pabinger-Fasching (= 1×) peers S.J. Machin

Countries citing papers authored by Ingrid Pabinger-Fasching

Since Specialization
Citations

This map shows the geographic impact of Ingrid Pabinger-Fasching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Pabinger-Fasching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Pabinger-Fasching more than expected).

Fields of papers citing papers by Ingrid Pabinger-Fasching

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Pabinger-Fasching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Pabinger-Fasching. The network helps show where Ingrid Pabinger-Fasching may publish in the future.

Co-authorship network of co-authors of Ingrid Pabinger-Fasching

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Pabinger-Fasching. A scholar is included among the top collaborators of Ingrid Pabinger-Fasching based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Pabinger-Fasching. Ingrid Pabinger-Fasching is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Königsbrügge, Oliver, Bernhard Scheiner, Benedikt Simbrunner, et al.. (2023). Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension. Thrombosis Research. 222. 124–130. 3 indexed citations
2.
Pabinger-Fasching, Ingrid. (2016). The story of a unique molecule in hemophilia A: recombinant single-chain factor VIII. Thrombosis Research. 141. S2–S4. 6 indexed citations
3.
Pabinger-Fasching, Ingrid, Sabine Eichinger-Hasenauer, Josef G. Grohs, et al.. (2014). Thromboseprophylaxe in der muskuloskelettalen Chirurgie. Wiener klinische Wochenschrift. 126(9-10). 298–310. 3 indexed citations
4.
Freynhofer, Matthias K., Dominik F. Draxler, Johann Wojta, et al.. (2013). Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillation. Journal of Thrombosis and Haemostasis. 11(6). 1069–1077. 11 indexed citations
5.
Watzke, Herbert, Helfried Metzler, Ansgar Weltermann, et al.. (2013). Niedermolekulare Heparine zur Überbrückung der Pause von Vitamin-K-Antagonisten während interventioneller Eingriffe – Expertenkonsensus. Wiener klinische Wochenschrift. 125(13-14). 412–420. 1 indexed citations
6.
Hauser, Lorenz, et al.. (2005). The Course of Anticardiolipin Antibody Levels Under Immunoadsorption Therapy. American Journal of Kidney Diseases. 46(3). 446–454. 10 indexed citations
7.
Hauser, Anna, Ingrid Pabinger-Fasching, Peter Quehenberger, Joachim Kettenbach, & Walter H. Hörl. (2003). A patient with sudden abdominal pain 10 years after successful renal transplantation. Nephrology Dialysis Transplantation. 18(5). 1021–1025. 2 indexed citations
8.
Hauser, Anna, et al.. (2003). Fibrinolytic therapy with rt-PA in a patient with paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome. Annals of Hematology. 82(5). 299–302. 14 indexed citations
9.
10.
Lalouschek, Wolfgang, S Aull, Wolfgang Serles, et al.. (2000). The Relation Between Erythrocyte Volume and Folate Levels is Influenced by a Common Mutation in the Methylenetetrahydrofolate Reductase (MTHFR) Gene (C677T). Journal of Investigative Medicine. 48(1). 14–20. 12 indexed citations
11.
Lalouschek, Wolfgang, S Aull, Christine Mannhalter, et al.. (1998). 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke. Journal of the Neurological Sciences. 155(2). 156–162. 7 indexed citations
12.
Ruzicka, Katharina, Stylianos Kapiotis, Peter Quehenberger, et al.. (1997). EVALUATION OF A NEW SCREENING ASSAY PROC® GLOBAL FOR IDENTIFICATION OF DEFECTS IN THE PROTEIN C/PROTEIN S ANTICOAGULANT PATHWAY. Thrombosis Research. 87(6). 501–510. 21 indexed citations
13.
Kapiotis, Stylianos, Peter Quehenberger, Bernd Jilma, et al.. (1996). Improved Characteristics of aPC-Resistance Assay:Coatest aPC Resistance by Predilution of Samples With Factor V Deficient Plasma. American Journal of Clinical Pathology. 106(5). 588–593. 22 indexed citations
14.
Mannucci, Pier Mannuccio, A. Gringeri, Geoffrey F. Savidge, et al.. (1994). Randomized double‐blind, placebo‐controlled trial of twice‐daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. British Journal of Haematology. 86(1). 174–179. 13 indexed citations
15.
Walter, Johannes, et al.. (1994). Symptomatic hereditary type-II protein C deficiency caused by a missense mutation in exon IX of the protein C gene (Gly381 to Ser). Annals of Hematology. 68(5). 255–259. 3 indexed citations
16.
Poort, S R, Ingrid Pabinger-Fasching, Christine Mannhalter, P H Reitsma, & R M Bertina. (1993). Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency. Blood Coagulation & Fibrinolysis. 4(2). 273–280. 26 indexed citations
17.
Pabinger-Fasching, Ingrid. (1991). [Blood coagulation disorders in leukemia].. PubMed. 141(9-10). 213–6. 1 indexed citations
18.
Sunder‐Plassmann, Gere, Wolfgang Speiser, C Korninger, et al.. (1991). Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. Annals of Hematology. 62(5). 169–173. 6 indexed citations
19.
Speiser, Wolfgang, Ingrid Pabinger-Fasching, Paul A. Kyrle, et al.. (1990). Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: Activation of blood coagulation, fibrinolysis and unspecific proteolysis. Annals of Hematology. 61(5). 298–302. 30 indexed citations
20.
Pabinger-Fasching, Ingrid & Klaus Lechner. (1984). [Protein C deficiency and thrombosis diathesis].. PubMed. 111(4). 416–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026